Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
ENTELLUS MEDICAL INC (ENTL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/28/2018 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 02/26/2018 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 01/04/2018 |
8-K
| Quarterly results |
| 12/07/2017 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : December 7, 2017 ENTELLUS MEDICAL, INC. Delaware 001-36814 20-4627978 3600 Holly Lane North, Suite 40 Plymouth, Minnesota 55447 463-1595 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☒ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to R...",
"Agreement and Plan of Merger, by and among Stryker Corporation, Explorer Merger Sub Corp. and Entellus Medical, Inc. (filed herewith)",
"Form of Voting Agreement, by and between Stryker Corporation and the applicable stockholder of Entellus Medical, Inc. (filed herewith)",
"Contact: Lynn Pieper Lewis 415-937-5402 [email protected] Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Share in Cash" |
|
| 11/01/2017 |
8-K
| Quarterly results |
| 09/25/2017 |
8-K
| Quarterly results |
| 08/08/2017 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 08/03/2017 |
8-K
| Quarterly results |
| 07/14/2017 |
8-K
| Form 8-K - Current report: |
| 07/07/2017 |
8-K
| Form 8-K - Current report |
| 06/14/2017 |
8-K
| Form 8-K - Current report |
| 05/03/2017 |
8-K
| Form 8-K - Current report |
| 04/12/2017 |
8-K
| Form 8-K - Current report |
| 04/06/2017 |
8-K
| Form 8-K - Current report |
| 02/21/2017 |
8-K
| Form 8-K - Current report |
| 01/31/2017 |
8-K
| Form 8-K - Current report |
| 01/25/2017 |
8-K
| Form 8-K - Current report |
| 01/05/2017 |
8-K
| Form 8-K - Current report |
| 11/03/2016 |
8-K
| Form 8-K - Current report |
| 08/03/2016 |
8-K
| Form 8-K - Current report |
| 06/29/2016 |
8-K
| Form 8-K - Current report |
| 06/27/2016 |
8-K
| Form 8-K - Current report |
| 06/15/2016 |
8-K
| Form 8-K - Current report |
| 05/23/2016 |
8-K
| Form 8-K - Current report |
| 05/10/2016 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 05/04/2016 |
8-K
| Quarterly results |
| 02/24/2016 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 02/22/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/11/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/09/2015 |
8-K
| Quarterly results |
| 08/14/2015 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 08/06/2015 |
8-K
| Quarterly results |
| 07/09/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"ENTELLUS MEDICAL APPOINTS JOHN BAKEWELL TO ITS BOARD OF DIRECTORS PLYMOUTH, MN, July 9, 2015 — Entellus Medical, Inc. , a medical technology company focused on designing, developing and commercializing products for the minimally invasive treatment of chronic and recurrent sinusitis patients, today announced that John Bakewell, Chief Financial Officer of Lantheus Holdings, Inc. , has been appointed to its Board of Directors and will be serving on the audit committee, effective July 7, 2015. Mr. Bakewell is an accomplished senior executive with more than twenty years of financial and administrative leadership experience concentrated in the medical device and healthcare provider sectors. Over the course of his career, Mr. Bakewell has held the role of Chief Financial Officer at seven companie..." |
|
| 07/07/2015 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits|
Docs:
|
"Commercial Lease dated February 27, 2012, by and between MU Plymouth Ponds LLC and Entellus Medical, Inc., relating to 3600 Holly Lane North, Plymouth, MN",
"Commercial Lease dated February 27, 2012, by and between MU Plymouth Ponds LLC and Entellus Medical, Inc., relating to 3600 Holly Lane North, Plymouth, MN",
"Commercial Lease dated June 30, 2014, by and between MU Plymouth Ponds LLC and Entellus Medical, Inc., relating to 3500 Holly Lane North, Plymouth, MN",
"Commercial Lease dated June 30, 2014, by and between MU Plymouth Ponds LLC and Entellus Medical, Inc., relating to 3500 Holly Lane North, Plymouth, MN",
"ENTELLUS MEDICAL EXPANDS CAPACITY TO ACCOMMODATE GROWTH PLYMOUTH, MN, July 7, 2015 — Entellus Medical, Inc. , a medical technology company focused on designing, developing and commercializing products for the minimally invasive treatment of chronic and recurrent sinusitis patients, today announced that it has entered into a lease agreement for approximately 19,700 additional square feet to its existing premises in Plymouth, MN. The Company is expected to be in possession of the additional space beginning in February 2016. The Company's lease of the Plymouth facility has a term expiring in June 2021, with an option to extend the term for an additional three years. “We expect this additional space will enable us to meet the needs of our rapidly expanding business and continue to lead in cust..." |
|
|
|
|